[HTML][HTML] Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
F Massari, A Rizzo, V Mollica, M Rosellini… - European Journal of …, 2021 - Elsevier
Background Recent years have witnessed the advent of novel treatment options for
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
F Massari, A Rizzo, V Mollica… - … journal of cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Recent years have witnessed the advent of novel treatment options for
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials.
F Massari, A Rizzo, V Mollica, M Rosellini… - European Journal of …, 2021 - europepmc.org
Background Recent years have witnessed the advent of novel treatment options for
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
F Massari, A Rizzo, V Mollica, M Rosellini… - European Journal of …, 2021 - ejcancer.com
Background Recent years have witnessed the advent of novel treatment options for
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
F Massari, A Rizzo, V Mollica, M Rosellini… - EUROPEAN JOURNAL …, 2021 - cris.unibo.it
Background: Recent years have witnessed the advent of novel treatment options for
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
[引用][C] Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
F Massari, A Rizzo, V Mollica, M Rosellini… - European Journal of …, 2021 - cir.nii.ac.jp
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis
of randomised clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
of randomised clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
F Massari, A Rizzo, V Mollica, M Rosellini… - EUROPEAN JOURNAL …, 2021 - cris.unibo.it
Background: Recent years have witnessed the advent of novel treatment options for
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …
metastatic renal cell carcinoma (mRCC), including combination therapies with immune …